Dr. William Shrank is the chief medical officer of the University of Pittsburgh Medical Center’s (UPMC’s) Health Plan Division. In this role, Dr. Shrank focuses on the design and implementation of new payment and delivery models to promote improved population health and the advancement of UPMC’s integrated clinical business strategies.


Prior to joining UPMC, Dr. Shrank served as senior vice president, chief scientific officer, and chief medical officer of provider innovation for CVS Health, where he led the development of solutions to support providers in managing risk and delivering better care to the populations they serve. Prior to joining CVS, Dr. Shrank served as the inaugural director of research and rapid-cycle evaluation for the Center for Medicare and Medicaid Innovation at the Centers for Medicare and Medicaid Services, where he helped design and led the evaluation of new payment reform models tested by the Innovation Center such as Pioneer accountable care organizations, bundled payments, and progressive primary care models. Dr. Shrank began his career as a practicing physician with Brigham Internal Medicine Associates at Brigham and Women’s Hospital in Boston, as well as an assistant professor at Harvard Medical School. His research at Harvard focused on improving the quality of prescribing and the use of chronic medications and he published more than 200 papers on these topics.


Dr. Shrank received his medical degree from Cornell University Medical College, served his residency in internal medicine at Georgetown University, and was a fellow in health policy research at the University of California, Los Angeles (UCLA), RAND. He earned his Masters of Science degree in health services from UCLA and his Bachelor’s Degree from Brown University.


Recent Posts by William Shrank

Mandating Coverage Of Abuse-Deterrent Opioids Would Be A Costly Distraction From More Effective Solutions

It is tempting to see abuse-deterrent opioids as a powerful and singular solution that might go a long way toward addressing our nation’s opioid crisis. But, it is not so simple.

Market Momentum, Spillover Effects, And Evidence-Based Decision Making On Payment Reform

With so many diverse reforms taking place, how is it possible to generate the evidence needed for informed decision making about payment reforms for the future?

Diffusion Of Innovations In Health Care—Obtaining Evidence To Move Faster

The growing field of implementation science offers exciting opportunities to improve the diffusion of innovations in the health care delivery system.

HHS And CVS Health Partner To Promote Consumer-Centered Preventive Services

The Office of Disease Prevention and Health Promotion and CVS Health recently formed a public-private partnership aiming to increase awareness of the availability of convenient, consumer-centered, recommended preventive services using healthfinder.gov.

In The Debate About Cost And Efficacy, PCSK9 Inhibitors May Be The Biggest Challenge Yet

The American health care system is far and away the most costly in the world. Health care reform is intended to lower costs, but they are still rising, albeit less steeply than in the past. Moderation is not however the case in the area of specialty pharmacy. The medications to treat Hepatitis...

Integrity In Retail Health Care: Rethinking The Sale Of Tobacco Products

Retail health care is a relatively new development in American health care.  It is true that much of the dispensing of medications has historically occurred through retail pharmacies, which sold a variety of other goods and services, but somehow that was not seen as the provision of health...

Correcting The Blind Spot In Accountability: The Role Of Pharmacy Care

Editor's note: In addition to William Shrank, this post is also coauthored by Andrew Sussman, Patrick Gilligan, and Troyen Brennan. The Centers for Medicare and Medicaid Services (CMS) recently issued a Request for Information (RFI) to solicit suggestions about how to improve the Accountable...